Merck and ISB Collaborate to Understand and Treat SARS-CoV-2 Infection

heath.isbscience.org/2020/04/27/merck-isb-covid/

Posted on April 27, 2020

COVID-19 Immune Response Study Could Lead to More Effective Treatments
Posted on October 28, 2020
Findings from the ISB-Swedish COVID-19 Immune Response Study suggest that treatments aimed at arresting the infection at the stage of moderate severity may be most effective. The team studied 139 patients and found that mild COVID-19 is very distinct from the moderate or severe forms of disease, which appear surprisingly similar.
Dr. Knatokie Ford Shares STEM Journey, Learnings and Advice in ISB-Town Hall Seattle Livestream
Posted on July 31, 2020
Dr. Knatokie Ford was the featured speaker of a virtual event hosted by ISB and Town Hall Seattle, and shared many of the experiences that helped pave her way to become a leading voice in STEM policy and advocacy, and identified several ways parents and teachers can encourage kids to become tomorrow’s STEM professionals.
ISB Builds Digital Platform for COVID-19 Research Study – and Beyond
Posted on July 9, 2020
In a multi-institutional study of a highly infectious disease like COVID-19, paperless consent for study participants is critical. One component of the COVID-19 Immune Response Study is a recruitment website with an IRB-approved and HIPAA-compliant electronic consent platform for enrolling patients.

at ISB